As the Centers for Medicare and Medicaid Services calls for public feedback on how to stop lab test fraud, experts say a tailored regulatory strategy will be key to avoid stifling innovation.

Researchers analyzed molecular sensitization patterns in Polish patients with perennial allergic rhinitis who tested positive for cockroach allergens. They found that most apparent cockroach allergies ...

This article is authored by Dr Kirti Chadha, chief scientific and innovation officer, Metropolis Healthcare Limited.

Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

Joining forces with GFE allows us to connect complementary areas of expertise within molecular diagnostics and blood ...

Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL ...

Janina Krumbeck, PhD, discusses the clinical advantages of next-generation sequencing over traditional culture and how this untargeted diagnostic approach provides comprehensive pathogen ...

More than $1.1 million in new provincial funding is accelerating cancer research in Sudbury, supporting a homegrown technology that could change how oncologists assess chemotherapy effectiveness.

Cambridge researchers map the convergence of biomarkers, digital phenotyping, and AI toward biologically grounded ...

GenomOncology, a leading precision medicine software company, today announced a strategic partnership with WeTrials, an AI-powered patient engagement and trial enablement platform, to help CNS cancer ...

University of Edinburgh spin-out BIOCAPTIVA secures £1.58m funding and launches its msX liquid biopsy technology in the US to improve cancer diagnostics and research.

Foundation Medicine, Inc., a global precision medicine company, today announced the launch of its Whole Genome Sequencing (WGS) Germline test for research use. This important portfolio expansion is ...